Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 31

Sort by

Sort Order Select

Meeting Abstracts

1923-LB: FRONTIER—Flash Glucose Monitoring System Use in Ontario among Patients with DM in the ICES Database—Evidence from Real-World Practice

STEWART B. HARRIS, RÉMI P. RABASA-LHORET, ALEXANDRIA RATZKI-LEEWING, YEESHA POON

Diabetes 2024;73(Supplement_1):1923-LB

https://doi.org/10.2337/db24-1923-LB

Published: 14 June 2024

View article titled, 1923-LB: FRONTIER—Flash Glucose Monitoring System Use in Ontario among Patients with DM in the ICES Database—Evidence from Real-World Practice

Meeting Abstracts

21-PUB: Meaningful Improvements in Treatment Satisfaction with Gla-300 in Insulin-Naïve PwT2D—A Post Hoc Analysis of Real-World ATOS PRO Study

STEWART B. HARRIS, NIAZ KHAN, AMIR TIROSH, JOTHYDEV KESAVADEV, HERNANDO VARGAS-URICOECHEA, AUDE ROBOREL DE CLIMENS, HOUSSEM BAGHOUS, FRANK J. SNOEK, MARIA AILEEN N. MABUNAY, NATASA GRULOVIC, VALERIE CORP DIT GENTI, JEROME MSIHID, GAGIK R. GALSTYAN

Diabetes 2024;73(Supplement_1):21-PUB

https://doi.org/10.2337/db24-21-PUB

Published: 14 June 2024

View article titled, 21-PUB: Meaningful Improvements in Treatment Satisfaction with Gla-300 in Insulin-Naïve PwT2D—A Post Hoc Analysis of Real-World ATOS PRO Study

Meeting Abstracts

1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective

STEWART B. HARRIS, SAL CIMINO, THI THANH YEN NGUYEN, YEESHA POON, KIRK SZAFRANSKI

Diabetes 2024;73(Supplement_1):1051-P

https://doi.org/10.2337/db24-1051-P

Published: 14 June 2024

View article titled, 1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective

Meeting Abstracts

175-OR: Level 3 Hypoglycemia in Diabetes—An Age-Old but Not (Just) Old-Age Problem (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2024;73(Supplement_1):175-OR

https://doi.org/10.2337/db24-175-OR

Published: 14 June 2024

View article titled, 175-OR: Level 3 Hypoglycemia in Diabetes—An Age-Old but Not (Just) Old-Age Problem (iNPHORM, USA)

Meeting Abstracts

369-P: How Common Is Fear of Hypoglycemia in Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus? (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2024;73(Supplement_1):369-P

https://doi.org/10.2337/db24-369-P

Published: 14 June 2024

View article titled, 369-P: How Common Is Fear of Hypoglycemia in Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus? (iNPHORM, USA)

Meeting Abstracts

1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial

ZUBIN PUNTHAKEE, STEPHANIE HALL, NATALIA MCINNES, DIANA SHERIFALI, KATE TSIPLOVA, MAHUA GHOSH, STEWART B. HARRIS, HEATHER A. LOCHNAN, THOMAS P.P. RANSOM, RONALD J. SIGAL, TAMARA SPAIC, HERTZEL C. GERSTEIN

Diabetes 2024;73(Supplement_1):1870-LB

https://doi.org/10.2337/db24-1870-LB

Published: 14 June 2024

View article titled, 1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial

Journal Articles

Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

Kira Zhi Hua Lai, Zhila Semnani-Azad, Beatrice A. Boucher, Ravi Retnakaran, Stewart B. Harris, Vasanti Malik, Richard P. Bazinet, Anthony J. Hanley

Diabetes 2023;72(11):1664–1670

https://doi.org/10.2337/db22-1050

Published: 16 August 2023

View article titled, Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

Meeting Abstracts

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2023;72(Supplement_1):3-OR

https://doi.org/10.2337/db23-3-OR

Published: 20 June 2023

View article titled, 3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

Meeting Abstracts

387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, GUANGYONG ZOU, BRIDGET L. RYAN, STEWART B. HARRIS

Diabetes 2023;72(Supplement_1):387-P

https://doi.org/10.2337/db23-387-P

Published: 20 June 2023

View article titled, 387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

Meeting Abstracts

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

ALICE Y. CHENG, RONALD GOLDENBERG, IRIS E. KRAWCHENKO, RICHARD TYTUS, JINA HAHN, AIDEN R. LIU, TOMMY LAN, BRADLEY MILLSON, STEWART B. HARRIS

Diabetes 2022;71(Supplement_1):268-OR

https://doi.org/10.2337/db22-268-OR

Published: 01 June 2022

View article titled, 268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

Meeting Abstracts

680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

STEWART B. HARRIS, FLEUR LEVRAT-GUILLEN

Diabetes 2022;71(Supplement_1):680-P

https://doi.org/10.2337/db22-680-P

Published: 01 June 2022

View article titled, 680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

Meeting Abstracts

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

ALICE Y. CHENG, STEWART B. HARRIS, IRIS E. KRAWCHENKO, RICHARD TYTUS, JINA HAHN, AIDEN R. LIU, YANG WANG, SHANE GOLDEN, RONALD GOLDENBERG

Diabetes 2022;71(Supplement_1):1241-P

https://doi.org/10.2337/db22-1241-P

Published: 01 June 2022

View article titled, 1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

Meeting Abstracts

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

NIAZ KHAN, AMIR TIROSH, ANIL BHANSALI, HERNANDO VARGAS-URICOECHEA, STEWART B. HARRIS, AUDE ROBOREL DE CLIMENS, MARIA AILEEN N. MABUNAY, MATHIEU COUDERT, VALERIE PILORGET, GAGIK R. GALSTYAN

Diabetes 2022;71(Supplement_1):813-P

https://doi.org/10.2337/db22-813-P

Published: 01 June 2022

View article titled, 813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

Meeting Abstracts

512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

STEWART B. HARRIS, JOCHEN SEUFERT, MONICA BERTOLINI, VALERY WALKER, JOHN C. WHITE, FANG L. ZHOU, KAMEL MOHAMMEDI, JOHN E. ANDERSON

Diabetes 2022;71(Supplement_1):512-P

https://doi.org/10.2337/db22-512-P

Published: 01 June 2022

View article titled, 512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

Meeting Abstracts

379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

STEWART B. HARRIS, KAMEL MOHAMMEDI, MONICA BERTOLINI, VALERY WALKER, MAUREEN H. CARLYLE, FANG L. ZHOU, JOCHEN SEUFERT, JOHN E. ANDERSON

Diabetes 2022;71(Supplement_1):379-P

https://doi.org/10.2337/db22-379-P

Published: 01 June 2022

View article titled, 379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

Meeting Abstracts

372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

ALEXANDRIA RATZKI-LEEWING, STEWART B. HARRIS, JASON E. BLACK, GUANGYONG ZOU, SUSAN WEBSTER-BOGAERT, BRIDGET L. RYAN

Diabetes 2022;71(Supplement_1):372-P

https://doi.org/10.2337/db22-372-P

Published: 01 June 2022

View article titled, 372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

Meeting Abstracts

371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

ALEXANDRIA RATZKI-LEEWING, STEWART B. HARRIS, JASON E. BLACK, GUANGYONG ZOU, SUSAN WEBSTER-BOGAERT, BRIDGET L. RYAN

Diabetes 2022;71(Supplement_1):371-P

https://doi.org/10.2337/db22-371-P

Published: 01 June 2022

View article titled, 371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

Meeting Abstracts

721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

VANITA R. ARODA, MORTEN T. ABILDLUND, RIKKE AGESEN, STEWART B. HARRIS, BANAFSHEH ZAHEDI, BERNARD ZINMAN, EIICHI ARAKI

Diabetes 2022;71(Supplement_1):721-P

https://doi.org/10.2337/db22-721-P

Published: 01 June 2022

View article titled, 721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

Meeting Abstracts

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

NATALIA MCINNES, STEPHANIE HALL, HEATHER A. LOCHNAN, STEWART B. HARRIS, ZUBIN PUNTHAKEE, RONALD J. SIGAL, IRENE HRAMIAK, MOHAMMED AZHARUDDIN, JOANNE F. LIUTKUS, JEAN-FRANÇOIS YALE, FARAH SULTAN, ADA C. SMITH, ROSE E. OTTO, DIANA SHERIFALI, YAN YUN LIU, HERTZEL C. GERSTEIN, REMIT-IGLARLIXI COLLABORATIVE GROUP

Diabetes 2021;70(Supplement_1):677-P

https://doi.org/10.2337/db21-677-P

Published: 01 June 2021

View article titled, 677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

Meeting Abstracts

347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

ALEXANDRIA RATZKI-LEEWING, JASON E. BLACK, BRIDGET L. RYAN, GUANGYONG ZOU, STEWART B. HARRIS

Diabetes 2021;70(Supplement_1):347-P

https://doi.org/10.2337/db21-347-P

Published: 01 June 2021

View article titled, 347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

NARROW

1923-LB: FRONTIER—Flash Glucose Monitoring System Use in Ontario among Patients with DM in the ICES Database—Evidence from Real-World Practice

21-PUB: Meaningful Improvements in Treatment Satisfaction with Gla-300 in Insulin-Naïve PwT2D—A Post Hoc Analysis of Real-World ATOS PRO Study

1051-P: Cost-Effectiveness of Flash CGM Compared with SMBG—A Canadian Private-Payer Perspective

175-OR: Level 3 Hypoglycemia in Diabetes—An Age-Old but Not (Just) Old-Age Problem (iNPHORM, USA)

369-P: How Common Is Fear of Hypoglycemia in Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus? (iNPHORM, USA)

1870-LB: Evaluating Remission of Type 2 Diabetes Using a Metabolic Intervention Including Fixed-Ratio Insulin Degludec and Liraglutide—A Randomized Controlled Trial

Association of Serum Very-Long-Chain Saturated Fatty Acids With Changes in Insulin Sensitivity and β-Cell Function: The Prospective Metabolism and Islet Cell Evaluation (PROMISE) Cohort

3-OR: Severe Hypoglycemia among Older Adults with Diabetes (iNPHORM, USA)

387-P: High Incidences of Level 3 Severe Hypoglycemia Reported by T2DM Secretagogue-Users (iNPHORM, USA)

268-OR: Impact of the COVID-Pandemic on Antihyperglycemic Prescription Patterns in Canada

680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database

1241-P: Cross-Sectional Study of the Impact of the COVID-Pandemic on Diabetes Management in Primary Care in Ontario, Canada

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

512-P: Physician Perspectives and Experiences with Basal Insulin Titration in Type 2 Diabetes: A U.S. Cross-Sectional Survey

379-P: Patient and Physician Experience of Hypoglycemia during Basal Insulin (BI) Titration in Type 2 Diabetes (T2D) in the U.S.

372-P: Predicting Real-World Severe Hypoglycemia in Americans with Diabetes (iNPHORM)

371-P: Predicting Real-World Nonsevere Hypoglycemia in Americans with Diabetes (iNPHORM)

721-P: Insulin-Sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8

677-P: Remission of Type 2 Diabetes following Intensive Treatment with Insulin Glargine, Lixisenatide, Metformin, and Lifestyle Approaches: Results of a Multicenter Randomized Controlled Trial

347-P: Why Some Americans Use Health Care following Severe Hypoglycemia, and Why Some Do Not: Baseline Results of the iNPHORM Study

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only